WASHINGTON (Reuters) – The U.S. Food and Drug Administration authorized Pfizer Inc’s COVID-19 vaccine for emergency use on Friday, the New York Times reported, citing two people with knowledge of the decision who spoke on condition of anonymity.
(Reporting by Eric Beech; Editing by Leslie Adler)
